​

United Therapeutics Ownership | Who Owns United Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

United Therapeutics Ownership Summary

United Therapeutics is owned by 97.35% institutional investors, 1.82% insiders, and 0.83% retail investors. Wealthfront advisers is the largest institutional shareholder, holding 41.06% of UTHR shares. iShares Core S&P Mid-Cap ETF is the top mutual fund, with 3.21% of its assets in United Therapeutics shares.

UTHR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockUnited Therapeutics97.35%1.82%0.83%
SectorHealthcare Stocks 279.18%10.62%-189.80%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Wealthfront advisers18.31M41.06%$18.26M
Blackrock funding, inc. /de5.36M12.01%$1.89B
Blackrock5.47M11.64%$1.74B
Vanguard group4.44M9.96%$1.57B
Avoro capital advisors2.76M6.19%$973.94M
Wellington management group llp2.46M5.52%$869.36M
State street2.29M4.88%$730.83M
Renaissance2.09M4.68%$737.22M
Fmr1.47M3.30%$519.17M
Geode capital management1.14M2.55%$401.18M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Krensavage asset management118.21K17.29%$37.66M
Avoro capital advisors2.76M13.78%$973.94M
Palo alto investors lp155.71K8.51%$54.94M
Nepsis54.92K4.84%$19.38M
Summit street capital management32.44K4.07%$11.45M
Poplar forest capital59.88K3.89%$21.13M
Nitorum capital95.42K3.87%$33.67M
Birchview capital, lp10.00K2.88%$3.53M
Soleus capital management109.39K2.43%$38.60M
Polaris capital management131.85K2.24%$46.52M

Top Buyers

HolderShares% AssetsChange
Wealthfront advisers18.31M0.06%18.31M
Norges bank430.12K0.02%430.12K
Fmr1.47M0.03%393.78K
State street2.29M0.03%359.11K
Amundi472.99K0.06%307.96K

Top Sellers

HolderShares% AssetsChange
Citadel advisors---719.31K
Wellington management group llp2.46M0.16%-706.96K
Squarepoint ops---177.50K
Point72 asset management---162.70K
Avidity partners management lp---110.00K

New Positions

HolderShares% AssetsChangeValue
Norges bank430.12K0.02%430.12K$151.76M
Raymond james financial51.74K0.01%51.74K$18.26M
Susquehanna fundamental investments50.53K0.25%50.53K$17.83M
Readystate asset management lp25.40K0.26%25.40K$8.09M
Bioimpact capital23.00K1.15%23.00K$8.12M

Sold Out

HolderChange
Financial synergies wealth advisors-1.00
Financial gravity asset management-1.00
Transamerica financial advisors-1.00
Opal wealth advisors-2.00
Tfo-tdc-2.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025670-2.33%43,709,344-0.77%971.00%338-9.38%2236.70%
Dec 31, 2024628-1.10%59,260,45237.20%1321.42%3408.63%191-15.49%
Sep 30, 20246267.56%43,411,015-5.14%971.03%3080.65%22315.54%
Jun 30, 20245736.90%45,745,1772.56%971.08%30010.70%1929.09%
Mar 31, 20245360.19%44,601,6301.10%941.08%2710.37%1763.53%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Mid-Cap ETF1.45M3.21%940.00
Vanguard Total Stock Mkt Idx Inv1.44M3.19%22.72K
Vanguard US Total Market Shares ETF1.41M3.14%1.06K
Vanguard Small Cap Index1.13M2.50%6.66K
Vanguard Health Care Inv910.86K2.02%7.39K
Vanguard Small Cap Value Index Inv728.89K1.62%2.30K
Vanguard Institutional Extnd Mkt Idx Tr690.54K1.53%3.64K
FullerThaler Behavioral Small-Cap Equity501.33K1.12%-34.60K
Vanguard Windsor Investor Shares488.35K1.09%-40.43K
FullerThaler Behavioral Sm-Cp Eq R6462.63K1.03%-38.70K

Recent Insider Transactions

DateNameRoleActivityValue
Jun 09, 2025EDGEMOND JAMES CFO AND TREASURERSell$32.83K
Jun 09, 2025EDGEMOND JAMES CFO AND TREASURERSell$2.50M
Jun 09, 2025EDGEMOND JAMES CFO AND TREASURERSell$1.17M
Jun 09, 2025EDGEMOND JAMES CFO AND TREASURERSell$99.60K
Jun 09, 2025EDGEMOND JAMES CFO AND TREASURERSell$98.04K

Insider Transactions Trends

DateBuySell
2025 Q2-46
2025 Q1-145
2024 Q4-174
2024 Q3-314
2024 Q2-357

UTHR Ownership FAQ

Who Owns United Therapeutics?

United Therapeutics shareholders are primarily institutional investors at 97.35%, followed by 1.82% insiders and 0.83% retail investors. The average institutional ownership in United Therapeutics's industry, Biotech Stocks , is 63.96%, which United Therapeutics exceeds.

Who owns the most shares of United Therapeutics?

United Therapeutics’s largest shareholders are Wealthfront advisers (18.31M shares, 41.06%), Blackrock funding, inc. /de (5.36M shares, 12.01%), and Blackrock (5.47M shares, 11.64%). Together, they hold 64.71% of United Therapeutics’s total shares outstanding.

Does Blackrock own United Therapeutics?

Yes, BlackRock owns 11.64% of United Therapeutics, totaling 5.47M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.74B$. In the last quarter, BlackRock decreased its holdings by -98.516K shares, a -1.77% change.

Who is United Therapeutics’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is United Therapeutics’s biggest shareholder by percentage of total assets invested, with 17.29% of its assets in 118.21K United Therapeutics shares, valued at 37.66M$.

Who is the top mutual fund holder of United Therapeutics shares?

iShares Core S&P Mid-Cap ETF is the top mutual fund holder of United Therapeutics shares, with 3.21% of its total shares outstanding invested in 1.45M United Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools